EPIZYME, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
EPIZYME, INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $0 as of 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2022-08-09
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $10.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $10.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $125.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $186.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.54M 10-K · filed 2021-02-23 |
| 2020-09-30 | $3.73M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $11.70M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $9.89M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $28.60M 10-K · filed 2020-02-27 |
| 2019-09-30 | $1.41M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $2.85M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $3.09M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $513.00K 10-K · filed 2019-02-26 |
| 2018-09-30 | $1.95M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $4.57M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $8.49M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $3.38M 10-K · filed 2018-03-13 |
| 2017-09-30 | $8.06M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $6.19M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $6.75M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $3.11M 10-K · filed 2017-03-13 |
| 2016-09-30 | $2.33M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $2.38M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $10.02M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $14.04M 10-K · filed 2016-03-09 |
| 2015-09-30 | $11.29M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $31.79M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $23.79M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $23.11M 10-K · filed 2015-03-12 |
| 2014-09-30 | $40.38M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $63.04M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $52.99M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $53.16M 10-K · filed 2014-02-28 |
| 2013-09-30 | $100.49M 10-Q · filed 2013-10-23 |
| 2013-06-30 | $65.58M 10-Q · filed 2013-08-01 |